Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.”
Email: jackfriday2011(at)hotmail.co.uk
Thursday, December 24, 2009
Sanofi-Aventis - Multaq: not worth it!
Sanofi-Aventis has failed to win early support from the UK's health costs board NICE for its Multaq heart drug on the state-run National Health Service because it is too pricey and no better than existing treatments.
No comments:
Post a Comment